Rapid Micro Biosystems Q1 revenue up 11% to $8.0M; net loss widens to $14.3M

RAPID MICRO BIOSYSTEMS, INC.

Total revenue $8.0M (+11% YoY); product revenue $5.6M (+36%).
Net loss $14.3M ($0.31/sh) vs $11.3M ($0.26/sh) in Q1 2025.
Recurring revenue $5.1M (+28%), 63% of total; placed 6 Growth Direct systems (3 in Q1 2025).
Gross margin 4.6% vs 5.6% last year; cash and equivalents $23M.
Reaffirms FY2026 guidance: revenue $37-41M, 30-38 system placements, ~20% gross margin.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

RAPID MICRO BIOSYSTEMS, INC. reported full year 2026 results: revenue full year 2026 total revenue guidance range of $37.0 million to $41.0 million. Guidance reaffirmed.

Period: full year 2026
Revenue: full year 2026 total revenue guidance range of $37.0 million to $41.0 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Reaffirms full year 2026 total revenue guidance range of $37.0 million to $41.0 million including a range of 30 to 38 Growth Direct system placements

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

RAPID MICRO BIOSYSTEMS, INC. reported first quarter ended March 31, 2026 results: revenue Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte, net income Net loss for the first quarter of 2026 was $14.3 million, EPS net loss per share was $0.31.

Period: first quarter ended March 31, 2026
Revenue: Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte
Net income: Net loss for the first quarter of 2026 was $14.3 million
EPS: net loss per share was $0.31
Result: reported results

Exact text from the filing

Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarter of 2025.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

Period: first quarter ended March 31, 2026
Revenue: Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte
Net income: Net loss for the first quarter of 2026 was $14.3 million
EPS: net loss per share was $0.31
Result: reported results

Exact text from the filing

Net loss for the first quarter of 2026 was $14.3 million and net loss per share was $0.31, compared to a net loss of $11.3 million and net loss per share of $0.26 in the first quarter of 2025.

View on SEC.gov

41 earnings releases filed in the last 30 days. Browse all earnings releases →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-26-000067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.